165 related articles for article (PubMed ID: 22543247)
1. Selective estrogen receptor modulation in pancreatic β-cells and the prevention of type 2 diabetes.
Tiano J; Mauvais-Jarvis F
Islets; 2012; 4(2):173-6. PubMed ID: 22543247
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes.
Tiano JP; Delghingaro-Augusto V; Le May C; Liu S; Kaw MK; Khuder SS; Latour MG; Bhatt SA; Korach KS; Najjar SM; Prentki M; Mauvais-Jarvis F
J Clin Invest; 2011 Aug; 121(8):3331-42. PubMed ID: 21747171
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic β-cells.
Tiano JP; Mauvais-Jarvis F
Endocrinology; 2012 Jul; 153(7):2997-3005. PubMed ID: 22564979
[TBL] [Abstract][Full Text] [Related]
4. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival.
Liu S; Le May C; Wong WP; Ward RD; Clegg DJ; Marcelli M; Korach KS; Mauvais-Jarvis F
Diabetes; 2009 Oct; 58(10):2292-302. PubMed ID: 19587358
[TBL] [Abstract][Full Text] [Related]
5. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
[TBL] [Abstract][Full Text] [Related]
7. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
[TBL] [Abstract][Full Text] [Related]
8. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
9. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
Weatherman RV; Clegg NJ; Scanlan TS
Chem Biol; 2001 May; 8(5):427-36. PubMed ID: 11358690
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
Thiebaud D; Secrest RJ
Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
[TBL] [Abstract][Full Text] [Related]
11. The selective oestrogen receptor modulators idoxifene and raloxifene have fundamentally different cell-specific oestrogen-response element (ERE)-dependent/independent mechanisms in vitro.
Nuttall ME; Fisher PW; Suva LJ; Gowen M
Eur J Cancer; 2000 Sep; 36 Suppl 4():S63-4. PubMed ID: 11056323
[TBL] [Abstract][Full Text] [Related]
12. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Ishihara Y; Itoh K; Ishida A; Yamazaki T
J Steroid Biochem Mol Biol; 2015 Jan; 145():85-93. PubMed ID: 25305410
[TBL] [Abstract][Full Text] [Related]
13. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
15. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of action of selective estrogen receptor modulators in breast and osteoblastic cells.
Nuttall ME; Stroup GB; Fisher PW; Nadeau DP; Gowen M; Suva LJ
Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1550-7. PubMed ID: 11029302
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis.
Zhou F; Dong H; Liu Y; Yan L; Sun C; Hao P; Liu Y; Zhai J; Liu Y
Brain Res Bull; 2018 Jun; 140():281-290. PubMed ID: 29807145
[TBL] [Abstract][Full Text] [Related]
18. Identification of selective estrogen receptor modulators by their gene expression fingerprints.
Zajchowski DA; Kauser K; Zhu D; Webster L; Aberle S; White FA; Liu HL; Humm R; MacRobbie J; Ponte P; Hegele-Hartung C; Knauthe R; Fritzemeier KH; Vergona R; Rubanyi GM
J Biol Chem; 2000 May; 275(21):15885-94. PubMed ID: 10748166
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
